tiprankstipranks
AnaptysBio price target lowered to $36 from $90 at Guggenheim
PremiumThe FlyAnaptysBio price target lowered to $36 from $90 at Guggenheim
10d ago
AnaptysBio price target lowered to $40 from $56 at Wells Fargo
Premium
The Fly
AnaptysBio price target lowered to $40 from $56 at Wells Fargo
10d ago
AnaptysBio downgraded to Neutral from Buy at H.C. Wainwright
Premium
The Fly
AnaptysBio downgraded to Neutral from Buy at H.C. Wainwright
11d ago
AnaptysBio trading halted, news pending
PremiumThe FlyAnaptysBio trading halted, news pending
11d ago
AnaptysBio downgraded to Neutral from Buy at BTIG
Premium
The Fly
AnaptysBio downgraded to Neutral from Buy at BTIG
20d ago
AnaptysBio price target lowered to $66 from $75 at JPMorgan
Premium
The Fly
AnaptysBio price target lowered to $66 from $75 at JPMorgan
1M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
2M ago
H.C. Wainwright still ‘optimistic’ on Phase 2 data for AnaptysBio’s rosnilimab
Premium
The Fly
H.C. Wainwright still ‘optimistic’ on Phase 2 data for AnaptysBio’s rosnilimab
2M ago
AnaptysBio weakness on competitor news a buying opportunity, says Guggenheim
Premium
The Fly
AnaptysBio weakness on competitor news a buying opportunity, says Guggenheim
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100